EPO and Iron deficiency anemia: The marked reduction in maternal and neonatal total-FGF23 concentrations after antenatal iron supplementation is in keeping with previous studies (6, 7) and is likely caused by a reversal of hypoxia and/or EPO-driven FGF23 gene expression in osteocytes that occurs in iron deficiency (7).